These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8436812)

  • 1. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts.
    Sonoda Y; Streilein JW
    J Immunol; 1993 Mar; 150(5):1727-34. PubMed ID: 8436812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic privilege evoked by histoincompatible intracameral retinal transplants.
    Jiang LQ; Streilein JW
    Reg Immunol; 1990-1991; 3(3):121-30. PubMed ID: 2098067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
    Niederkorn JY; Mayhew E; Mellon J; Hegde S
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens.
    Williamson JS; Streilein JW
    Reg Immunol; 1988; 1(1):15-23. PubMed ID: 2978942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY; Mellon J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
    Hori J; Joyce NC; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
    Wilbanks GA; Mammolenti M; Streilein JW
    J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antigen-bearing eye and the spleen are indispensable in maintaining anterior chamber-associated immune deviation.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):534-9. PubMed ID: 9040487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice.
    Peeler J; Niederkorn J; Matoba A
    Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1516-23. PubMed ID: 2414248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.